AI Article Synopsis

  • - The study in Manaus revealed that actual COVID-19 cases in early 2022 were as much as 8 times higher than what was officially reported.
  • - Vaccination efforts helped lower mortality rates but didn't reach the necessary immunity levels to prevent severe cases, particularly with the emergence of new Omicron variants.
  • - To effectively reduce severe COVID-19 cases, vaccination rates need to exceed 90-95% across all age groups, along with regular booster shots every four months.

Article Abstract

We followed the COVID-19 pandemic in Manaus, one of the epicenters of COVID-19 in Brazil, using an epidemiological mathematical model and made five main conclusions. First, in early 2022, the actual cases exceed officially reported data by up to 8 times. Second, despite vaccination campaigns, the collective immunity threshold necessary was insufficient to contain severe cases of COVID-19. Next, the low observed mortality demonstrated the effectiveness of vaccination. Next, the drop in the vaccination rate combined with immune escape by the Omicron sub-variants (BA.2.12.1, BA.4, and BA.5) resulted in new wave after November 2022. Finally, to minimize severe cases of COVID-19, we need to raise vaccination thresholds above 90-95% of the entire population including children aged 6 months and older and require booster doses at least in four-month intervals. This approach would help to prevent severe cases of COVID-19 that cause hospitalizations and deaths.

Download full-text PDF

Source
http://dx.doi.org/10.1057/s41271-024-00530-0DOI Listing

Publication Analysis

Top Keywords

severe cases
16
cases covid-19
16
brazil epidemiological
8
covid-19
6
cases
5
high transmission
4
transmission sars-cov-2
4
sars-cov-2 amazonia
4
amazonia brazil
4
epidemiological strategy
4

Similar Publications

Background: Aicardi-Goutières Syndrome is a monogenic type 1 interferonopathy with infantile onset, characterized by a variable degree of neurological damage. Approximately 7% of Aicardi-Goutières Syndrome cases are caused by pathogenic variants in the ADAR gene and are classified as Aicardi-Goutières Syndrome type 6. Here, we present a new homozygous pathogenic variant in the ADAR gene.

View Article and Find Full Text PDF

Towards a histological diagnosis of childhood small vessel CNS vasculitis.

Pediatr Rheumatol Online J

December 2024

Section of Rheumatology, Department of Pediatrics, Alberta Children's Hospital, University of Calgary, Calgary, Canada.

Background: Primary small vessel CNS vasculitis (sv-cPACNS) is a challenging inflammatory brain disease in children. Brain biopsy is mandatory to confirm the diagnosis. This study aims to develop and validate a histological scoring tool for diagnosing small vessel CNS vasculitis.

View Article and Find Full Text PDF

Antegrade femoral puncture Using a Suture-Mediated Closure Device in infrainguinal endovascular interventions.

Ann Vasc Surg

December 2024

Department of Vascular Surgery, IRCCS Sacro Cuore-Don Calabria, Negrar, VR, Italy.

Introduction: ProGlide is a suture-mediated vascular closure device (VCD) indicated for retrograde access closure at the common femoral artery (CFA). However, its off-label use for antegrade and/or superficial femoral artery (SFA) access has become common in many practices. This study evaluated the efficacy and safety of ProGlide for femoral artery access closure in patients undergoing antegrade infrainguinal endovascular procedures.

View Article and Find Full Text PDF

Outcomes Comparison of Endovascular and Open Surgical Approaches for Subclavian Arterial Injury: A Nationwide Analysis.

Ann Vasc Surg

December 2024

Comparative Effectiveness and Clinical Outcomes Research Center, Riverside University Health System, Moreno Valley, CA, USA; Loma Linda University School of Medicine, Loma Linda, CA, USA. Electronic address:

Background: The management of patients with subclavian artery injury is rapidly evolving from an open to an endovascular approach. We aim to present an analysis of management and a comparison of outcomes according to the type of approach used to treat these challenging injuries.

Methods: Adult patients with subclavian arterial injuries were abstracted from the National Inpatient Sample database from 2012 to 2014 and 2016 to 2021.

View Article and Find Full Text PDF

Persistence, severity and reactivity thresholds in fish allergic patients sensitized to parvalbumin.

J Allergy Clin Immunol Pract

December 2024

Servicio de Alergia, Hospital Clínico San Carlos, IdISSC, Madrid, Spain; Facultad de Medicina, Universidad Complutense, Madrid, Spain. Electronic address:

Background: Fish allergy affects children and adults worldwide and there are transient and persistent phenotypes.

Objective: We aimed to analyze persistence, severity and reactivity thresholds in challenge-confirmed fish allergic patients sensitized to parvalbumin.

Methods: Patients 12-65 years-old reporting immediate reactions to fish, with fish skin prick test ≥5 mm and IgE to cod and carp β-parvalbumins ≥0.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!